10-Q: Nortech Systems Reports Mixed Results in Second Quarter 2024 Amidst Market Shifts

Nortech Systems experienced a slight decrease in net sales and a significant drop in operating income for the second quarter of 2024, while also managing a facility closure and changes in customer ordering patterns.

Summary

• Nortech Systems reported a decrease in net sales for both the three and six months ended June 30, 2024, with sales of $33.89 million and $68.11 million respectively, compared to $35.02 million and $69.91 million in the same periods of 2023.
• The company's gross profit also declined, with a gross margin of 13.6% for the three months and 14.8% for the six months ended June 30, 2024, compared to 15.6% and 15.7% in the corresponding periods of 2023.
• Operating income decreased significantly to $344,000 for the three months and $1.5 million for the six months ended June 30, 2024, compared to $1.1 million and $2.2 million in the same periods of 2023.
• Net income was $157,000 for the three months and $922,000 for the six months ended June 30, 2024, compared to $634,000 and $1.3 million in the same periods of 2023.
• The company's 90-day shipment backlog was $30.1 million as of June 30, 2024, down 14.5% from March 31, 2024, and 12.2% from June 30, 2023.
• Total order backlog was $73.3 million as of June 30, 2024, a 14.8% decrease from the prior quarter end and a 27.4% decrease from the prior-year comparable quarter end.
• Restructuring charges of $91,000 were incurred in the first six months of 2024 related to the closure of the Blue Earth facility, with an estimated $800,000 in total restructuring costs expected in 2024.
• The company's line of credit had borrowings of $8.36 million outstanding as of June 30, 2024, with $6.44 million of unused availability.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive aspects, such as growth in the aerospace and defense sector, but the overall tone is negative due to decreased sales, profits, and backlog. The restructuring costs and facility closure also contribute to the negative sentiment.

Positives

• Net sales in the aerospace and defense sector increased by 23.9% and 29.3% for the three and six months ended June 30, 2024, respectively.
• The company met all financial covenants related to its credit agreement, except for one which was waived by the bank.
• The company has unused availability of $6.44 million on its line of credit.
• The company is transitioning manufacturing from the Blue Earth facility to the Bemidji plant, which may lead to future efficiencies.

Negatives

• Net sales in the medical sector decreased by 13.3% and 11.9% for the three and six months ended June 30, 2024, respectively.
• The company experienced a significant decrease in operating income and net income compared to the same periods in 2023.
• The company's backlog has decreased significantly, indicating potential future revenue challenges.
• The company incurred restructuring charges related to the closure of the Blue Earth facility.
• The company had a decrease in cash from operating activities compared to the same period last year.

Risks

• The company faces risks related to market volatility, supply chain disruptions, and competition within the EMS industry.
• The company is exposed to risks related to the loss of major customers and changes in customer ordering practices.
• The company is subject to risks related to compliance with securities and environmental regulations.
• The company is exposed to risks related to outbreaks of epidemic, pandemic, or contagious diseases.
• The company is exposed to risks related to commodity and energy cost instability.

Future Outlook

The company believes that its existing financing arrangements, anticipated cash flows from operations, and cash on hand will be sufficient to satisfy its working capital needs for the next twelve months, capital expenditures, and debt repayments. The company also expects to incur approximately $800,000 of cash restructuring costs related to the Blue Earth facility closure in 2024.

Management Comments

• Management noted that the decrease in medical sales was due to inventory re-balancing with existing customers, timing of customer product launches, and lower average sales prices in anticipation of moving several programs for one customer to the Monterrey, Mexico facility.
• Management stated that the increase in aerospace and defense sales was due to increasing demand and improved supply chain availability.
• Management mentioned that customers are returning to pre-pandemic ordering practices, which has resulted in a decrease in backlog.
• Management noted reduced visibility to revenues in the next several quarters as customers are rebalancing their inventories.

Industry Context

The company operates in the Electronic Manufacturing Services (EMS) industry, which is subject to fluctuations in demand, supply chain disruptions, and competition. The decrease in backlog and medical sales may reflect broader trends in the industry, such as inventory adjustments by customers and shifts in demand across different sectors. The increase in aerospace and defense sales aligns with the current growth in that sector.

Comparison to Industry Standards

• The company's gross margin of 13.6% for the three months ended June 30, 2024, is below the average gross margin for the EMS industry, which typically ranges from 15% to 20%.
• Companies like Jabil and Flex, which are major players in the EMS industry, often report higher gross margins due to their scale and diversified customer base.
• The decrease in Nortech's backlog is a concern, as it indicates a potential slowdown in future revenue. This contrasts with some EMS companies that have maintained or increased their backlogs due to strong demand in certain sectors.
• The restructuring costs associated with the Blue Earth facility closure are not uncommon in the EMS industry, as companies often need to optimize their operations to remain competitive. However, the magnitude of the costs may be significant for a company of Nortech's size.
• The company's reliance on a few major customers, as indicated by the concentration of sales and accounts receivable, is a risk that is common in the EMS industry, but it is important to diversify the customer base to mitigate this risk.

Related Party Transactions

• The company has accounts receivable related to Abilitech Medical, Inc., of which the full amount has been allowed for due to Abilitech ceasing operations.
• The company has an agreement with Marpe Technologies, LTD, for a grant from the BIRD Foundation, with the company providing services at cost or no cost to Marpe.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net sales, profits, and backlog.
• Employees at the Blue Earth facility will be affected by the closure and consolidation.
• Customers may experience changes in lead times and pricing due to the facility consolidation.
• Suppliers may be affected by changes in the company's production volumes and material requirements.

Next Steps

• The company plans to complete the closure and consolidation of its Blue Earth facility by the fourth quarter of 2024.
• The company will continue to monitor its financial performance and adjust its operations as needed.
• The company will continue to manage its supply chain and customer relationships.

Key Dates

Keywords

contract manufacturing, EMS, medical devices, aerospace and defense, industrial, backlog, supply chain, restructuring, financial results, revenue